Abstract
Editorial Note:
The weekly medical journal of The Netherlands – the Nederlands Tijdschrift Door Geneeskunde – has for many years periodically sponsored expert meetings to consider medical topics of current importance. On June 15th 1990, the Journal held a conference on the situation created by the promised common market for pharmaceutical products which is to be created by the European Community. The views expressed there represented professional reactions in one member state to a development which has been motivated by international economic interests rather than considerations of health or medical care. The report which follows appears simultaneously in Dutch in The Netherlands (Ned Tijdschr Geneesk 1990; 134, Nr. 38).